Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Jaguar Health, Inc. < Previous 1 2 3 Next > Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions July 05, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 01, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China June 29, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi June 22, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 June 21, 2022 From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Tickers JAGX Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients June 13, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders June 10, 2022 From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Tickers JAGX Jaguar Health to Participate in BIO International Convention (BIO 2022) June 10, 2022 From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Tickers JAGX Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications June 09, 2022 From Jaguar Health, Inc. Via AccessWire Topics Economy Exposures Supply Chain Tickers JAGX Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition May 25, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week May 24, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index May 23, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd! May 19, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd! May 17, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health May 11, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Announces Launch of Mytesi Telehealth Program May 11, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials May 10, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 06, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates May 05, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates May 05, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs May 03, 2022 From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Tickers JAGX Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs April 27, 2022 From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Tickers JAGX Jaguar Health to Present at the NobleCon18 Investor Conference on April 21, 2022 April 20, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4) April 15, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Animal Health to Host Dinner & Tableside Discussion for U.S. Veterinary Oncologists About Chemotherapy-Induced Diarrhea (CID) in Dogs on April 12th, the Final Day of the Veterinary Cancer Society (VCS) Mid-Year Conference in Puerto Vallarta, Mexico April 06, 2022 From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Tickers JAGX Jaguar Health Announces Appointment of Pravin Chaturvedi, Ph.D., as Chief Scientific Officer April 05, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Enters Exclusive Crofelemer Distribution and License Agreement with Quadri Pharmaceuticals Store for Multiple Target Indications in Middle East Markets March 31, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX Jaguar Health Shares Replay Link for March 14, 2022, Investor Webcast March 14, 2022 From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Tickers JAGX Jaguar Health Provides Company Updates and Reports 2021 Financials March 11, 2022 From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Tickers JAGX Jaguar Health to Host Investor Webcast Monday, March 14th at 8:30 AM Eastern Time Regarding Q4 2021 Financials & Corporate Updates March 07, 2022 From Jaguar Health, Inc. Via AccessWire Tickers JAGX < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.